Earnings (Loss) Per Share

12 Months Ended

Dec. 31, 2023

Basic earnings (loss) per share applicable to common stockholders is computed by dividing earnings (loss) applicable to common stockholders by the weighted average number of common shares outstanding. Diluted earnings (loss) per share assumes the conversion of any convertible securities using the treasury stock method or the if-converted method.


	For the year ended December 31,
(In thousands, except per share data)	2023		2022
Numerator:
Net loss attributable to UpHealth, Inc.	$	(57,839)	$	(223,000)
Denominator:
Weighted average shares outstanding	17,724		14,699
Net loss per share attributable to UpHealth, Inc.:
Basic and diluted	$	(3.26)	$	(15.17)

The calculation of basic and dilutive earnings per share excluded the following because the effect would be anti-dilutive:


	For the year ended December 31,
(In thousands, except per share data)	2023	2022
2021 Public, Private and PIPE Warrants at a $115.00 per share conversion price	1,812	1,812
2023 Private Placement Series A and B Warrants at a $2.04 per share conversion price	6,000	—
Stock options	48	138
Restricted stock units	722	878
2025 Notes at a $17.50 per share conversion price(1)	3,857	3,857
2026 Notes at a $106.50 per share conversion price	1,080	1,502
Forward share purchase agreement	—	170

(1) Subject to the occurrence of certain corporate events.